Skip to main content
ENDO 2026 Main banner

Topic: Reproductive Endocrinology
Session Type: Symposium

SY73 - From PCOS to PMOS: Rationale and Clinical Implications of a New Nomenclature

Saturday, June 13, 2026
4:30 PM - 6:00 PM CT
Location: Room W183BC

    Symposium Moderator(s)

  • AD

    Anuja Dokras, MD, MHCI, PhD

    Dept of OBGYN
    Department of Obstetrics and Gynecology, Division of Reproductive Endocrinology, Hospital of the University of Pennsylvania
    Philadelphia, United States

    Disclosure information not submitted.

  • MC

    Melanie Cree, MD, PhD (she/her/hers)

    Professor
    Pediatric Endocrinology
    University of Colorado Anschutz
    Aurora, Colorado, United States

    Disclosure information not submitted.

This session will present the rationale and evidence supporting the transition from PCOS to PMOS as the preferred nomenclature. Expert panelists will discuss the development process and key considerations for clinical practice. Attendees will gain practical insights into how this change may impact diagnosis, communication, and patient care.

Presentations:

  • 4:30 PM - 4:40 PM CT
    Introduction and Overview

    Symposium Moderator: Anuja Dokras, MD, MHCI, PhD – Department of Obstetrics and Gynecology, Division of Reproductive Endocrinology, Hospital of the University of Pennsylvania

    Symposium Moderator: Melanie G. Cree, MD, PhD (she/her/hers) – University of Colorado Anschutz

  • 4:40 PM - 4:45 PM CT
    From PCOS to PMOS: Rationale and Clinical Implications of a New Nomenclature

    Symposium Speaker: Ricardo Azziz, MBBS, Ph.D (he/him/his) – UNIVERSITY OF ALABAMA AT BIRMINGHAM

  • 4:45 PM - 4:50 PM CT
    From PCOS to PMOS: Rationale and Clinical Implications of a New Nomenclature

    Symposium Speaker: Selma Feldman Witchel, MD (she/her/hers) – UPMC Children's Hospital of Pittsburgh University of Pittsburgh

  • 4:50 PM - 4:55 PM CT
    From PCOS to PMOS: Rationale and Clinical Implications of a New Nomenclature

    Symposium Speaker: Melanie G. Cree, MD, PhD (she/her/hers) – University of Colorado Anschutz

  • 4:55 PM - 5:00 PM CT
    From PCOS to PMOS: Rationale and Clinical Implications of a New Nomenclature

    Symposium Speaker: Shruthi Mahalingaiah, MD, MS – Harvard T.H. Chan School of Public Health

  • 5:00 PM - 5:05 PM CT
    From PCOS to PMOS: Rationale and Clinical Implications of a New Nomenclature

    Symposium Speaker: Miyuki Harada, PhD,MD (she/her/hers) – Obstetrics and Gynecology, The University of Tokyo

  • 5:05 PM - 5:10 PM CT
    From PCOS to PMOS: Rationale and Clinical Implications of a New Nomenclature

    Symposium Speaker: Andrea Dunaif, MD – Icahn School of Medicine at Mount Sinai

  • 5:10 PM - 6:00 PM CT
    QA with the Audience

    Symposium Moderator: Anuja Dokras, MD, MHCI, PhD – Department of Obstetrics and Gynecology, Division of Reproductive Endocrinology, Hospital of the University of Pennsylvania

    Symposium Moderator: Melanie G. Cree, MD, PhD (she/her/hers) – University of Colorado Anschutz